Clinical trials
Terminated Phase 1/2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genmab | 3 |
| Pfizer | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
| Amgen | 1 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| Calithera Biosciences, Inc | 1 |
| CytoDyn, Inc. | 1 |
| Formation Biologics | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Hutchmed | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 35 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Squamous Cell Carcinoma of Head and Neck | 12 |
| Melanoma | 9 |
| Neoplasm Metastasis | 9 |
| Breast Neoplasms | 7 |
| Carcinoma, Renal Cell | 7 |
| Carcinoma, Transitional Cell | 7 |
| Ovarian Neoplasms | 7 |
| Colorectal Neoplasms | 6 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.